Table 3.
Comparison of intraoperative variables between external stent and internal stent group in high-risk of pancreatic fistula patients
| Variables | External stent group N = 43 | Internal stent group N = 129 | P-value |
|---|---|---|---|
| Preoperative biliary drainage | 12 (27.9%) | 27 (20.9%) | P = 0.344 |
| Percutaneous/endoscopic | 7/5 | 7/20 | |
| Preoperative total bilirubin (μmol/L) | 17.5 (11–135) | 28 (13.5–121.5) | P = 0.581 |
| Preoperative direct bilirubin (μmol/L) | 9.9 (4–107.3) | 9.7 (3–79.7) | P = 0.535 |
| Preoperative CA 199 (U/mL) | 20.7 (5.8–191) | 27 (7.9–156.2) | P = 0.965 |
| Operative time (min) | 492.16 ± 103.63 | 432.22 ± 136.51 | P = 0.003 |
| Intraoperative bleeding (mL) | 225 (200–400) | 200 (200–400) | P = 0.712 |
| ≤ 400 | 33 | 101 | |
| > 400 | 10 | 28 | |
| Vascular resection | 8 (18.6%) | 5 (3.9%) | P = 0.004 |
| Blood transfusion | 17 (39.5%) | 38 (29.5%) | P = 0.220 |
| Texture soft/Firm | 43/0 | 121/8 | P = 0.203 |
| Pancreatic duct diameter (cm) | 0.3(0.3–0.4) | 0.3 (0.3–0.3) | P = 0.205 |
| 0.1 | 1 | 0 | |
| 0.2 | 6 | 26 | |
| 0.3 | 22 | 76 | |
| 0.4 | 12 | 22 | |
| 0.5 | 2 | 4 | |
| > 0.5 | 0 | 1 | |
| Pathology | P = 0.002 | ||
| Pancreatic adenocarcinoma or pancreatitis | 13 | 14 | |
| Ampullary, duodenal, cystic, islet cell, etc | 30 | 115 | |
| Pancreatic adenocarcinoma | 12 | 12 | |
| Cholangiocarcinoma | 2 | 16 | |
| Duodenal carcinoma | 16 | 39 | |
| Chronic pancreatitis | 1 | 2 | |
| Pancreatic cystic tumor | 1 | 19 | |
| Pancreatic neuroendocrine tumor | 1 | 3 | |
| Ampullary carcinoma | 5 | 26 | |
| Others | 5 | 12 |
The italic values reflected that there was a significant difference between the two groups